Toll-Free: (855) 210-9006
SmartSkin Technologies will be attending the PDA/FDA Joint Regulatory Conference 2026, taking place September 14–16 in Washington, DC, one of the pharmaceutical industry’s most trusted forums for collaboration between global regulators and life sciences professionals. This flagship event brings together leaders across pharma and biotech to explore evolving regulatory expectations, share best practices in Current Good Manufacturing Practices (CGMP), and advance quality systems that ensure patient safety and product integrity.
At this year’s conference, SmartSkin will showcase how its advanced pharmaceutical solutions for proactive quality management, risk mitigation, and compliance across manufacturing environments. With a strong focus on data-driven insights, real-time monitoring, and seal assurance, SmartSkin aligns with the conference’s emphasis on building robust quality systems, improving inspection readiness, and enabling continuous process control throughout the product lifecycle.